- Country: Ukraine
- Summary: Omeprazole 40 Mg Vial
- UAT Ref No: 133298017
- Deadline: 09 Jan 2026
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 131780
- Notice Type: Tender
- Document Ref. No.: UA-2026-01-06-002343-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Purchase type: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products Omeprazole 40 mg bottle, bottle with lyophilisate in a pack with labeling in Ukrainian Name Classifier and its corresponding code Quantity/Units of measurement Place of delivery Date of delivery Name DK 021:2015: 33600000-6 — Pharmaceutical products Omeprazole 40 mg vial, vial with lyophilisate in a package with labeling in Ukrainian Name Classifier and its corresponding code Quantity/Units of measurement Place of delivery Delivery date Name Omeprazole 40 mg vial
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINOmeprazole 40 Mg Vial - Ukraine Tender
The COMMUNAL NON-PROFIT MEDICAL ENTERPRISE KREMENCHUK ANTI-TUMOR CENTER OF THE KREMENCHUK CITY COUNCIL OF THE KREMENCHUK DISTRICT OF THE POLTAVA REGION, a Government sector organization in Ukraine, has announced a new tender for Omeprazole 40 Mg Vial. This tender is published on UkraineTenders under UAT Ref No: 133298017 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2026-01-09.
The estimated tender value is UAH 131780, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
